By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Covance today said that it will collaborate with the Broad Institute on microRNA expression research on an unidentified research model.

Princeton, NJ-based Covance said that the collaboration will utilize its next-generation sequencing capabilities to profile microRNA expression in various tissue samples from the model, which the firm said has proven valuable for understanding various human diseases including respiratory, oncology, and cardiovascular diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.